Jubilant Epicore LLC

Chandru Gajendran

Sriram K Rajagopal

Sridharan Rajagopal

Chandrika Mulakala

Dhanalakshmi Sivanandhan

Subramanyam Janardhan Tantry

Purushottam Dewang

Kannan Murugan

Pravin Iyer

Sreekala Nair

Mahanandeesha S Hallur

Mohd Zainuddin

Durga Prasanna Kumar C H

Durga Prasanna Kumar CH

The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.

Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors

The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like. 

Growing community of inventors

Bengaluru, India

Chandru Gajendran